Novartis has lost its bid to have Pharmacor’s claim that its patent for a blood pressure drug is invalid decided ahead of a main trial where the Swiss pharmaceutical giant will allege the generic drug maker is threatening to infringe its patent.
ASIC has lost its challenge to findings that a revenue sharing arrangement between the Commonwealth Bank of Australia and former subsidiary Colonial First State Investments did not breach conflicted remuneration provisions of the Corporations Act.
A class action has challenged a decision that found the age pension does not discriminate against Indigenous Australians because of differences in life expectancy, arguing the Full Court settled for formal rather than substantive equality.
Jones Day has added a corporate transactions counsel who spent 12 years working in New York, most recently at Latham & Watkins LLP, to join its Sydney team.
A class action against Carnival over norovirus outbreaks on its Sun Princess cruise ship has defeated the cruise operator’s second strike out bid, with a judge saying the failure to identify what exactly went wrong “may not be fatal” to the case.
Retailer Best & Less will back-pay staff over $5.2 million as part of an undertaking to the Fair Work Ombudsman, after an internal review found salaried managers were not paid enough to cover their entitlements.
Noumi has admitted in a case by ASIC to breaching its continuous disclosure obligations by overstating the value of its inventory and failing to give a true and fair view of the company’s financial position.
IG Markets has been hit with a second class action for offering “highly risky and unsuitable financial products” to retail investors, with a third competing proceeding in the works.
A Blue Sky director has pointed the finger at auditor Ernst & Young in a class action alleging the collapsed investment firm misled shareholders by misstating its assets under management.
A judge has refused a lead applicant’s novel bid for financial information to use at settlement discussions in a group proceeding against Dixon Advisory.